Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
6.04
-0.04 (-0.66%)
At close: Jan 2, 2026, 4:00 PM EST
6.04
0.00 (0.00%)
After-hours: Jan 2, 2026, 4:10 PM EST
Exagen Market Cap
Exagen has a market cap or net worth of $136.89 million as of January 2, 2026. Its market cap has increased by 29.35% in one year.
Market Cap
136.89M
Enterprise Value
127.36M
1-Year Change
29.35%
Ranking
Category
Stock Price
$6.04
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $136.89M, an increase of 116.91%. That is a compound annual growth rate of 13.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 136.89M | -0.66% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |